A New Path to Sustainable Growth in Life Sciences
Macro healthcare trends could increase global healthcare spending by more than 5 percent annually through 2022.
This growth presents huge opportunities, but today’s life sciences companies must also confront significant challenges: increased regulation, declining access to physicians and other healthcare professionals, spiraling R&D costs and timelines, increased competition, patent cliffs, and slowing sales of medical devices.
The companies that are best poised to overcome those challenges and to seize the opportunity focus on developing lasting relationships with physicians and healthcare providers. Improving the patient experience and engaging patients have become more important, especially as customer expectations have risen. Digital agreements can play an outsized role in those relationship-building efforts among life sciences companies, customers, and patients.